The MaxCombo Test Severely Violates the Type I Error Rate
JAMA Oncol
.
2023 Apr 1;9(4):571-572.
doi: 10.1001/jamaoncol.2022.7747.
Authors
Dominic Magirr
1
,
Carl-Fredrik Burman
2
Affiliations
1
Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.
2
Statistical Innovation, Data Science & AI, AstraZeneca, Gothenburg, Sweden.
PMID:
36757691
DOI:
10.1001/jamaoncol.2022.7747
No abstract available
Publication types
Letter
Comment